Arora, Anmol http://orcid.org/0000-0003-4881-8293
Alderman, Joseph E. http://orcid.org/0000-0001-8273-9009
Palmer, Joanne http://orcid.org/0000-0002-1186-802X
Ganapathi, Shaswath http://orcid.org/0000-0003-2126-0007
Laws, Elinor http://orcid.org/0000-0002-5829-2224
McCradden, Melissa D. http://orcid.org/0000-0002-6476-2165
Oakden-Rayner, Lauren
Pfohl, Stephen R.
Ghassemi, Marzyeh http://orcid.org/0000-0001-6349-7251
McKay, Francis http://orcid.org/0000-0002-3177-9446
Treanor, Darren http://orcid.org/0000-0002-4579-484X
Rostamzadeh, Negar
Mateen, Bilal http://orcid.org/0000-0003-4423-6472
Gath, Jacqui http://orcid.org/0000-0001-8875-5894
Adebajo, Adewole O.
Kuku, Stephanie
Matin, Rubeta http://orcid.org/0000-0002-9695-5412
Heller, Katherine
Sapey, Elizabeth
Sebire, Neil J.
Cole-Lewis, Heather
Calvert, Melanie http://orcid.org/0000-0002-1856-837X
Denniston, Alastair http://orcid.org/0000-0001-7849-0087
Liu, Xiaoxuan http://orcid.org/0000-0002-1286-0038
Article History
Received: 14 March 2023
Accepted: 22 September 2023
First Online: 26 October 2023
Competing interests
: M.C. receives funding from the National Institute for Health and Care Research (NIHR), UKRI, NIHR Biomedical Research Centre, NIHR Surgical Reconstruction and Microbiology Research Centre, NIHR Applied Research Collaboration West Midlands, NIHR Birmingham-Oxford Blood and Transplant Research Unit in Precision Transplant and Cellular Therapeutics, UK SPINE, European Regional Development Fund—Demand Hub and Health Data Research UK at the University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, Innovate UK (part of UKRI), Macmillan Cancer Support, UCB Pharma, GSK and Gilead. M.C. has received personal fees from Astellas, Aparito, CIS Oncology, Takeda, Merck, Daiichi Sankyo, Glaukos, GSK and the Patient-Centered Outcomes Research Institute outside the submitted work. S.K. is a consultant for Hardian Health and vice president of Conceivable Life Sciences. S.R.P., N.R., H.C.-L. and K.H. are employees of Google. The remaining authors declare no competing interests.